Contract Drug Development Resource, goBalto, Launches New Web-Based Platform, goBalto.com
oBalto establishes new online platform to help pharmaceutical
companies find, evaluate and manage drug partners from around the
world, reducing inefficiencies in the drug development lifecycle
SAN
FRANCISCO/PRNewswire/ -- goBalto, an online drug development
partnering site for the pharmaceutical development and drug
manufacturing industry, announced today its new platform and website,
goBalto.com. goBalto transforms the way drug-development partners are
matched. The web-based platform enables members to quickly and
efficiently find partners, share knowledge, and discover opportunities.
"U.S. and EU pharmaceutical companies are under pressure to reduce
costs and boost efficiencies in the drug development process," said Jae
Chung, founder & CEO, goBalto. "As a result, companies are
increasingly looking towards outsourcing to help reduce costs. But it's
challenging for companies to identify and evaluate drug service
providers. goBalto is addressing this by creating an online resource
where users can quickly find and evaluate drug service providers,
resulting in improved transparency and better decision making."
goBalto incorporates the following key features for its members:
-- Search and browser tools to screen from more than 7,000 potential
service providers (investigator sites, CMOs, CROs, and consultants) to
help customers find the right partner
-- Lists of potential service providers based on technical capabilities,
regulatory compliance, facilities, equipment, and more
-- Capability to rate companies and post comments on vendors
-- Functionality to post about projects and jobs specific to the
pharmaceutical industry
-- Ability to make and share collections of vendors for each project
-- Easy to read vendor summary profiles, incorporating videos, images and
the latest in Web 2.0 technologies
"In today's highly competitive marketplace, it's critical to be able
to find quality partners that can reduce your costs of drug development
and time-to-market," said Dr. Cary Queen, Co-Founder of Protein Design
Labs. "The goBalto platform provides members with the transparency and
ability to quickly identify and evaluate new partners via a rating
system that includes rich vendor profiles."
"goBalto provides a great platform for showcasing our drug
development and manufacturing capabilities to biotech and
pharmaceutical companies around the globe," said Kiran-Mazumdar Shaw,
Chairman and Managing Director of Biocon Limited. "The goBalto
partnering website provides us with a highly cost-effective channel to
reach our target customers compared to traditional options such as
industry conferences and advertising."
According to market research company Kalorama, the market for
contract manufacturing of prescription drugs exceeded $30 billion last
year, a 10% increase over the previous year. "The sheer numbers of
biologics in the pipeline are driving drug makers to outsource
specialized production rather than build new plants," according to
Kalorama.
"Most existing sites are "one-way" distributors of content from the
publisher to the user," said Mr. Chung. "But users today are seeking a
more collaborative platform. We're not only improving transparency, but
incorporating the latest in Web social media tools to enable users to
share their collective experiences on topics ranging from vendors to
regions in which to conduct trials."
About Jae Chung, Founder and CEO
Jae Chung founded goBalto in October 2008. Prior to goBalto, he
co-founded Celltrion, a contract biopharmaceutical group in Asia. As
Celltrion's vice president of business development, he secured deals
with Bristol-Myers Squibb and CSL, and has been credited with landing
the largest biomanufacturing supply agreement in Asia to date. Before
starting Celltrion in 2002, he was the co-founder of the venture
capital firm, J. Stephen & Company Ventures, and a strategy
consultant at McKinsey and Company.
About goBalto
goBalto is a dedicated online drug development partnering site for
the pharmaceutical and drug manufacturing industry. Users can identify,
evaluate, and manage drug-development partners from around the world.
Incorporating the latest in Web 2.0 technologies, goBalto's platform
enables users to distinguish their offerings by adding logos, images,
videos, customer testimonials and post referrals from members. More
than 7,000 service providers are currently listed.
Related Link:
goBalto - http://www.gobalto.com/
Press contacts:
Jamie O'Donnell
SEO-PR
Jamie.odonnell@seo-pr.com
Phone 415 606 5914
press@gobalto.com
Phone 415 671 4372
For marketing opportunities, contact:
Erik Sam
goBalto, Director of Business Development
esam@gobalto.com
Phone 415 671 4372
Video:
http://news.prnewswire.com/viewrelease.aspx?STORY=MjU=
Source: goBalto
CONTACT: Jamie O'Donnell of SEO-PR, +1-415-606-5914,
Jamie.odonnell@seo-pr.com; or press@gobalto.com, +1-415-671-4372; For
marketing opportunities, Erik Sam, goBalto, Director of Business Development,
+1-415-671-4372, esam@gobalto.com
Web Site:
http://www.gobalto.com/
Read more